Q2 2021 Chugai Pharmaceutical Co Ltd Earnings Call Transcript
I am Dr. Osamu Okuda, President and CEO of Chugai Pharmaceutical. Let me give you the financial overview of the second quarter of fiscal 2021.
Please take a look at Page 5. Revenues from January through June totaled JPY 390.2 billion, up 6.0% year-on-year. The operating profit and net income for the second quarter soared by more than 15% from the year before. We started the first quarter with a drop in both revenues and profit but turning to positive year-on-year growth in revenues and profits for the first half.
Looking at the progress against the full year forecast. Domestic sales and ROI exceeded the forecast made at the beginning of the year. In particular, the growth in ROI was associated with the growth in overseas local sales of in-house products and, therefore, directly contributed to the profits. As a result, both operating profit and net income showed steady growth that surpassed the initial forecast.
As I explained in the next slide, in addition to those factors, there are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
